Citadel Advisors’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
78,765
+52,974
+205% +$1.13M ﹤0.01% 6543
2025
Q4
$595K Sell
25,791
-115,934
-82% -$2.92M ﹤0.01% 8614
2025
Q3
$4M Sell
141,725
-7,516
-5% -$207K ﹤0.01% 4760
2025
Q2
$4.13M Buy
149,241
+141,077
+1,728% +$4.17M ﹤0.01% 4437
2025
Q1
$263K Sell
8,164
-90
-1% -$2.92K ﹤0.01% 9875
2024
Q4
$262K Sell
8,254
-22,431
-73% -$692K ﹤0.01% 9930
2024
Q3
$885K Sell
30,685
-145,515
-83% -$4.17M ﹤0.01% 7111
2024
Q2
$4.92M Buy
176,200
+113,039
+179% +$3.01M ﹤0.01% 3766
2024
Q1
$1.68M Buy
63,161
+20,889
+49% +$559K ﹤0.01% 5862
2023
Q4
$1.14M Sell
42,272
-22,921
-35% -$569K ﹤0.01% 6422
2023
Q3
$1.41M Buy
65,193
+38,849
+147% +$858K ﹤0.01% 5900
2023
Q2
$647K Sell
26,344
-88,949
-77% -$2.21M ﹤0.01% 7374
2023
Q1
$3.12M Buy
115,293
+48,292
+72% +$1.2M ﹤0.01% 4566
2022
Q4
$1.66M Buy
67,001
+10,594
+19% +$254K ﹤0.01% 5829
2022
Q3
$1.2M Buy
56,407
+17,060
+43% +$388K ﹤0.01% 6596
2022
Q2
$854K Buy
39,347
+22,445
+133% +$448K ﹤0.01% 7386
2022
Q1
$337K Sell
16,902
-73,259
-81% -$1.66M ﹤0.01% 10324
2021
Q4
$2.38M Sell
90,161
-7,169
-7% -$190K ﹤0.01% 5844
2021
Q3
$2.78M Sell
97,330
-12,050
-11% -$352K ﹤0.01% 5545
2021
Q2
$3.06M Buy
109,380
+41,276
+61% +$1.04M ﹤0.01% 5557
2021
Q1
$1.52M Sell
68,104
-57,752
-46% -$1.38M ﹤0.01% 7059
2020
Q4
$2.75M Buy
125,856
+40,121
+47% +$806K ﹤0.01% 4725
2020
Q3
$1.72M Buy
85,735
+68,572
+400% +$1.46M ﹤0.01% 5011
2020
Q2
$380K Buy
17,163
+7,778
+83% +$180K ﹤0.01% 7529
2020
Q1
$225K Sell
9,385
-94,120
-91% -$2.36M ﹤0.01% 7817
2019
Q4
$2.81M Buy
103,505
+13,716
+15% +$377K ﹤0.01% 3877
2019
Q3
$2.32M Buy
89,789
+24,761
+38% +$665K ﹤0.01% 4241
2019
Q2
$1.68M Buy
65,028
+2,534
+4% +$66.6K ﹤0.01% 4813
2019
Q1
$1.75M Sell
62,494
-129,583
-67% -$3.41M ﹤0.01% 4681
2018
Q4
$4.64M Buy
192,077
+89,160
+87% +$2.31M ﹤0.01% 2896
2018
Q3
$3.19M Sell
102,917
-19,416
-16% -$581K ﹤0.01% 3627
2018
Q2
$3.34M Buy
122,333
+60,467
+98% +$1.6M ﹤0.01% 3320
2018
Q1
$1.54M Sell
61,866
-41,531
-40% -$998K ﹤0.01% 4133
2017
Q4
$2.4M Buy
103,397
+54,910
+113% +$1.29M ﹤0.01% 3381
2017
Q3
$1.13M Buy
48,487
+22,282
+85% +$530K ﹤0.01% 4143
2017
Q2
$689K Sell
26,205
-3,133
-11% -$86.1K ﹤0.01% 4655
2017
Q1
$711K Buy
+29,338
New +$684K ﹤0.01% 4488
2016
Q4
Sell
-14,006
Closed -$387K 7496
2016
Q3
$387K Sell
14,006
-30,129
-68% -$779K ﹤0.01% 5253
2016
Q2
$1.17M Buy
44,135
+1,269
+3% +$29.8K ﹤0.01% 3381
2016
Q1
$946K Sell
42,866
-5,543
-11% -$114K ﹤0.01% 3568
2015
Q4
$1.06M Buy
48,409
+2,305
+5% +$53.8K ﹤0.01% 3482
2015
Q3
$1.01M Buy
46,104
+20,873
+83% +$555K ﹤0.01% 3809
2015
Q2
$768K Sell
25,231
-48,606
-66% -$1.39M ﹤0.01% 4336
2015
Q1
$1.86M Sell
73,837
-420
-0.6% -$11.4K ﹤0.01% 3151
2014
Q4
$2.19M Buy
74,257
+27,374
+58% +$777K ﹤0.01% 2814
2014
Q3
$1.13M Buy
46,883
+6,557
+16% +$165K ﹤0.01% 3567
2014
Q2
$980K Buy
40,326
+11,194
+38% +$279K ﹤0.01% 3512
2014
Q1
$778K Buy
29,132
+21,462
+280% +$638K ﹤0.01% 3746
2013
Q4
$251K Buy
+7,670
New +$262K ﹤0.01% 4783

Other funds holding HSTM

Citadel Advisors's HSTM Position: Q1 2026 in Review

Citadel Advisors increased its HealthStream (HSTM) stake by 205% in Q1 2026, buying an estimated $1.13M and bringing the position to 78,765 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #6543.

Citadel Advisors first reported a position in HSTM in Q4 2013 and has held it in 49 quarters since. The position peaked at $4.92M in Q2 2024. 197 funds tracked by Wall St. Rank hold HSTM as of Q1 2026.

  • Citadel Advisors held 78,765 shares of HealthStream worth $1.63M as of Q1 2026.
  • Citadel Advisors bought 52,974 HealthStream shares in Q1 2026, an estimated $1.13M.
  • HealthStream made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6543 holding.
  • Citadel Advisors first reported a position in HealthStream in Q4 2013 and has held it in 49 quarters since.
  • Citadel Advisors's HealthStream position peaked at $4.92M in Q2 2024.
  • 197 funds tracked by Wall St. Rank held HealthStream as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.